Purpose of the development: Microcrystalline cellulose from domestic plant materials (flax and hemp) is intended for the production of solid dosage forms in the pharmaceutical industry as an alternative to the imported more expensive microcrystalline cellulose from softwood and cotton.

Recommended application field: The pharmaceutical industry.

Advantages over analogues: Microcrystalline cellulose from domestic plant materials meets the best foreign analogues and the requirements of domestic and European pharmacopeias.

The development stage readiness: Ready for application

Description of the development:
()
Domestic pharmaceutical companies annually purchase tens of tons of imported microcrystalline cellulose. The production of microcrystalline cellulose from domestic plant materials partially solves the problem of import substitution, reduces the cost of the final product by 20-30%, and increases the competitiveness of the production of domestic medicinal tablets.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua